Therapeutic strategies targeting AP2ε could aim to restore or stabilize the proliferative state (AP2εlow) while suppressing the quiescent, invasive state (AP2εhigh), potentially limiting tumor progression and metastasis. Here, TFAP2E is linked to neoplasm.